Enzyme-linked immunosorbent assays (ELISA) to detect antibodies against SARS-CoV-2, producing COVID-19, in human serum or plasma.
COVID-19 ELISA IgM+IgA
COVID-19 ELISA IgG
PRODUCT FEATURES
COVID-19 serology allows confirmation of infection in both symptomatic and asymptomatic patients. ELISA is a simple and easy to automate technique that allows high throughput tests at low cost.
IgM+IgA detecion complements molecular tests when the viral load decreases or when false negatives are suspected due to unsuitable samples in patients with clear symptoms. COVID-19 serology allows confirmation of infection in both symptomatic and asymptomatic patients. ELISA is a simple and easy to automate technique that allows high throughput tests at low cost. Excellent performance in samples characterized by PCR*
The combination of IgM+IgA significantly improves sensitivity since COVID-19 affects the mucous membrane. The early production of IgA antibodies in this kind of infections could be particularly high.
IgG detection allows disease monitoring when other molecular and serological markers become negative.